Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer

Virtual screening 0301 basic medicine 03 medical and health sciences Breast cancer Demethylzeylasteral ADP-ribosylation factor 1 Therapeutics. Pharmacology RM1-950 Letter to the Editor
DOI: 10.1016/j.apsb.2022.02.011 Publication Date: 2022-02-16T16:54:04Z